Peabody, MA – JEOL USA, Inc, a leader in the mass spectrometry space for over 60 years, has once again reimagined their single quadrupole instrument to meet the evolving needs of the scientific community. Officially termed the JMS-Q1600GC UltraQuad™ SQ-Zeta, this GC-Quadrupole Mass Spectrometer is equipped with high-performance capabilities for a wide variety of measurement... Read more
Danaher Partners with the University of Pennsylvania’s Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies WASHINGTON, March 7, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced a strategic partnership with the University of Pennsylvania (Penn) focusing on cell therapy innovation. The multi-year... Read more
Danaher Announces New Environmental and Applied Solutions Company to Be Named Veralto WASHINGTON, Feb. 8, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) today announced that Veralto Corporation (“Veralto” or the “Company”) will be the name of the separate public company Danaher intends to create in the fourth quarter of 2023. Veralto will be comprised... Read more
Thermo Fisher’s latest net-zero milestone to be achieved through 200-megawatt solar project WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it will power all of the company’s current U.S. sites with 100 percent renewable electricity by 2026. The company’s new 20-year virtual power purchasing agreement with... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter and Full Year 2022 Highlights Fourth quarter revenue grew 7% to $11.45 billion. Fourth quarter GAAP diluted earnings per share (EPS) was... Read more
WASHINGTON, Jan. 24, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2022. All results in this release reflect only continuing operations unless otherwise noted. Net earnings refers to net earnings attributable to common shareholders. For the quarter ended December 31, 2022, net earnings were... Read more
WASHINGTON, Dec. 27, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2022 on Tuesday, January 24, 2023 beginning at 8:00 a.m. ET and lasting approximately 1 hour. During the call, the company will discuss its financial performance, as well as future expectations.... Read more
Company to achieve 2030 Scope 1 and 2 greenhouse gas emissions reduction target of 30% ahead of schedule; increases ambition to 50% reduction, aligned with 1.5˚C pathway WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a new 2030 greenhouse gas emissions reduction target to reduce its... Read more
Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation WASHINGTON, Nov. 10, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation. Danaher Beacons is a... Read more
Chicago, US – November 10, 2022 – GE Healthcare has joined the Department of Health and Human Services (HHS) and the White House in the pledge to decarbonize the health care sector and make health care facilities more resilient to the effects of climate change. An affirmation of its climate goals, the pledge reinforces GE... Read more